← Leaderboards
Katherine Nickerson
Columbia University Health Sciences
$385,820
Attributed
$385,820
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$385,820 · 1
By mechanism
M01$385,820 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- David Armand Fidock$27,333,547
- Boris Reizis$28,563,580
- Krzysztof Kiryluk$17,737,105
- Xueling Wu$10,163,675
- Max Elliot Gottesman$13,676,838
Others in their field
Top investigators on “Cd40 Molecule”
- Jacques F Banchereau · Rockefeller University$17,936,253
- Rama Rao Amara · Emory University$11,504,642
- Yong-Jun Liu · University Of Texas Md Anderson Can Ctr$11,265,744
- Jerzy W. Kupiec-Weglinski · University Of California Los Angeles$9,822,350
- Lewis C Becker · Johns Hopkins University$8,751,227
- Randolph J. Noelle · University Of Minnesota$8,492,235
Research focus
Cd40 MoleculeClinical ResearchCombination TherapyGlomerulonephritisHuman SubjectHuman Therapy EvaluationImmunopathology TherapyInjection /InfusionNeutralizing AntibodySteroidsSystemic Lupus Erythematosus
Grant awards (5)
ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS$192,910
M01 · FY2002 · RR
ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS$192,910
M01 · FY2001 · RR
ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS$0
M01 · FY2001 · RR
ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS$0
M01 · FY2000 · RR
ANTI CD40L ANTIBODY IN SUBJECTS WITH PROLIFERATIVE LUPUS$0
M01 · FY2000 · RR